Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Hypercholesterolemia association with aortic stenosis of various etiologies.

Rabuş MB, Kayalar N, Sareyyüpoğlu B, Erkin A, Kirali K, Yakut C.

J Card Surg. 2009 Mar-Apr;24(2):146-50. doi: 10.1111/j.1540-8191.2009.00814.x.

PMID:
19267822
2.

Aortic sclerosis, aortic stenosis and lipid-lowering therapy.

Rosenhek R, Baumgartner H.

Expert Rev Cardiovasc Ther. 2008 Mar;6(3):385-90. doi: 10.1586/14779072.6.3.385. Review.

PMID:
18327997
3.

Pathogenesis and pathophysiology of aortic valve stenosis in adults.

Olszowska M.

Pol Arch Med Wewn. 2011 Nov;121(11):409-13. Review. English, Polish.

4.

Do statins improve outcomes and delay the progression of non-rheumatic calcific aortic stenosis?

Parolari A, Tremoli E, Cavallotti L, Trezzi M, Kassem S, Loardi C, Veglia F, Ferrari G, Pacini D, Alamanni F.

Heart. 2011 Apr;97(7):523-9. doi: 10.1136/hrt.2010.215046. Epub 2011 Jan 26. Review.

PMID:
21270077
5.

Calcific aortic valve disease and aortic atherosclerosis--two faces of the same disease?

Ginghină C, Florian A, Beladan C, Iancu M, Călin A, Popescu BA, Jurcuţ R.

Rom J Intern Med. 2009;47(4):319-29. Review.

PMID:
21179913
6.

Prediction of degeneration of native and bioprosthetic aortic valves: issue-related particularities of diabetes mellitus.

Yeghiazaryan K, Bauriedel G, Schild HH, Golubnitschaja O.

Infect Disord Drug Targets. 2008 Jun;8(2):88-99. Review.

PMID:
18537704
7.

Medical therapy for calcific aortic stenosis.

Salas MJ, Santana O, Escolar E, Lamas GA.

J Cardiovasc Pharmacol Ther. 2012 Jun;17(2):133-8. doi: 10.1177/1074248411416504. Epub 2011 Aug 9. Review.

PMID:
21828284
8.

Aortic valve stenosis and lipid-lowering therapy: the state of the art.

Bonadei I, Vizzardi E, D'aloia A, Gelsomino S, De Cicco G, Lorusso R, Dei Cas L.

Panminerva Med. 2013 Dec;55(4):391-5. Review.

PMID:
24434347
9.

Aortic valve calcification in chronic kidney disease.

Rattazzi M, Bertacco E, Del Vecchio A, Puato M, Faggin E, Pauletto P.

Nephrol Dial Transplant. 2013 Dec;28(12):2968-76. doi: 10.1093/ndt/gft310. Epub 2013 Oct 3. Review.

10.

The global burden of aortic stenosis.

Thaden JJ, Nkomo VT, Enriquez-Sarano M.

Prog Cardiovasc Dis. 2014 May-Jun;56(6):565-71. doi: 10.1016/j.pcad.2014.02.006. Epub 2014 Mar 2. Review.

PMID:
24838132
11.

Stroke secondary to calcific bicuspid aortic valve: case report and literature review.

Mahajan N, Khetarpal V, Afonso L.

J Cardiol. 2009 Aug;54(1):158-61. doi: 10.1016/j.jjcc.2008.10.011. Epub 2008 Dec 24. Review.

12.

SALTIRE-RAAVE: targeting calcific aortic valve disease LDL-density-radius theory.

Rajamannan NM, Greve AM, Moura LM, Best P, Wachtell K.

Expert Rev Cardiovasc Ther. 2015 Apr;13(4):355-67. doi: 10.1586/14779072.2015.1025058. Review.

PMID:
25797901
13.

The lipid theory in the pathogenesis of calcific aortic stenosis.

Parisi V, Leosco D, Ferro G, Bevilacqua A, Pagano G, de Lucia C, Perrone Filardi P, Caruso A, Rengo G, Ferrara N.

Nutr Metab Cardiovasc Dis. 2015 Jun;25(6):519-25. doi: 10.1016/j.numecd.2015.02.001. Epub 2015 Feb 12. Review.

PMID:
25816732
14.

Medical therapy for rheumatic heart disease: is it time to be proactive rather than reactive?

Rajamannan NM, Antonini-Canterin F, Moura L, Zamorano JL, Rosenhek RA, Best PJ, Lloyd MA, Rocha-Goncalves F, Chandra S, Alfieri O, Lancellotti P, Tornos P, Baliga RR, Wang A, Bashore T, Ramakrishnan S, Spargias K, Shuvy M, Beeri R, Lotan C, Suwaidi JA, Bahl V, Pierard LA, Maurer G, Nicolosi GL, Rahimtoola SH, Chopra K, Pandian NG.

Indian Heart J. 2009 Jan-Feb;61(1):14-23. Review.

15.

The response to valve injury. A paradigm to understand the pathogenesis of heart valve disease.

Li C, Xu S, Gotlieb AI.

Cardiovasc Pathol. 2011 May-Jun;20(3):183-90. doi: 10.1016/j.carpath.2010.09.008. Epub 2010 Nov 13. Review.

PMID:
21075649
16.

Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Rajamannan NM, Evans FJ, Aikawa E, Grande-Allen KJ, Demer LL, Heistad DD, Simmons CA, Masters KS, Mathieu P, O'Brien KD, Schoen FJ, Towler DA, Yoganathan AP, Otto CM.

Circulation. 2011 Oct 18;124(16):1783-91. doi: 10.1161/CIRCULATIONAHA.110.006767. Review. No abstract available.

17.

Calcific aortic stenosis: lessons learned from experimental and clinical studies.

Rajamannan NM.

Arterioscler Thromb Vasc Biol. 2009 Feb;29(2):162-8. doi: 10.1161/ATVBAHA.107.156752. Epub 2008 Nov 20. Review.

18.

[Functional vascular alterations associated with aortic valve stenosis].

Nemes A, Forster T.

Orv Hetil. 2011 Jun 19;152(25):993-9. doi: 10.1556/OH.2011.29145. Review. Hungarian.

PMID:
21642051
19.

[Prevalence and pathogenesis of aortic valve calcifications].

Koos R, Brandenburg V, Ketteler M, Kühl HP.

Herz. 2006 Oct;31(7):629-34. Review. German.

PMID:
17072775
20.

C-reactive protein in degenerative aortic valve stenosis.

Sanchez PL, Mazzone A.

Cardiovasc Ultrasound. 2006 Jun 14;4:24. Review.

Items per page

Supplemental Content

Write to the Help Desk